【醫(yī)學課件】isis-2研究ppt課件(編輯修改稿)
2024-11-13 02:53 本頁面
【文章內(nèi)容簡介】 RESULTS continued Days after randomization Cumulative no. of vascular deaths 0 7 14 21 28 35 50 600 400 200 800 1000 Vascular mortality over 35 days: individual therapies Odds reduction: 25%, SD 4 2P 1029 (%) Placebo infusion SK The ISIS2 collaborative group. Lancet 1988。 ii: 349–60. 791 (%) 0 7 14 21 28 35 50 600 400 200 800 1000 Odds reduction: 23%, SD 4 2P 1016 (%) Placebo tablets Aspirin 804 (%) ISIS2: Second International Study of Infarct Survival RESULTS continued Vascular mortality at 35 days in four treatment arms and bination The ISIS2 collaborative group. Lancet 1988。 ii: 349–60. Placebo infusion and tablets SK and aspirin Combination therapy pared with matched bination placebo Cumulative no. of vascular deaths Days after randomization 0 7 14 21 28 35 0 400 300 200 100 500 600 Odds reduction: 42%, SD 5 2P 568 (%) 343 (%) * Significantly higher than bination therapy: 2P
教學課件相關(guān)推薦
鄂ICP備17016276號-1